Chione Ltd

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Chione Ltd's trades of Acrivon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-28 2023-06-26
S Sale
23,528 +30.2%
346.83
US$363,849 		23,528 +30.2% 346.83 US$363,849
2023-06-20 2023-06-15
S Sale
41,295 +3.3%
296.66
US$1,870,598 		41,295 +3.3% 296.66 US$1,870,598
2023-06-14 2023-06-14
S Sale
94,119 +15.7%
478.38
US$3,540,695 		94,119 +15.7% 478.38 US$3,540,695
2023-06-14 2023-06-13
S Sale
3,000 -0.1%
12.30
US$36,900 		3,000 -0.1% 12.30 US$36,900
2023-06-14 2023-06-12
S Sale
2,000 -0.1%
12.34
US$24,680 		2,000 -0.1% 12.34 US$24,680
2023-06-12 2023-06-12
PrS Proposed sale
219,259
12.44
US$2,727,594 		219,259 12.44 US$2,727,594
2022-11-21 2022-11-17
B Purchase
400,000 +11.6%
12.50
US$5,000,000 		400,000 +11.6% 12.50 US$5,000,000
2019-03-04 2019-02-28
S Sale
149,624 -2.4%
4.14
US$619,114 		149,624 -2.4% 4.14 US$619,114
2019-02-27 2019-02-27
S Sale
558,243 -8.3%
4.51
US$2,515,834 		558,243 -8.3% 4.51 US$2,515,834
2019-02-27 2019-02-26
S Sale
123,400 -1.8%
5.00
US$617,210 		123,400 -1.8% 5.00 US$617,210
2019-02-27 2019-02-25
S Sale
800,000 -10.5%
4.99
US$3,994,880 		800,000 -10.5% 4.99 US$3,994,880